Gemina Laboratories (XCNQ:GLAB) COGS-to-Revenue : 0.00 (As of Apr. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories COGS-to-Revenue?

Gemina Laboratories's Cost of Goods Sold for the three months ended in Apr. 2024 was C$0.00 Mil. Its Revenue for the three months ended in Apr. 2024 was C$0.00 Mil.

Gemina Laboratories's COGS to Revenue for the three months ended in Apr. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Gemina Laboratories's Gross Margin % for the three months ended in Apr. 2024 was N/A%.

Gemina Laboratories COGS-to-Revenue Historical Data

The historical data trend for Gemina Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories COGS-to-Revenue Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

COGS-to-Revenue

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
COGS-to-Revenue	Get a 7-Day Free Trial								-	-	-	-	-

Gemina Laboratories COGS-to-Revenue Calculation

Gemina Laboratories's COGS to Revenue for the fiscal year that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Gemina Laboratories's COGS to Revenue for the quarter that ended in Apr. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Gemina Laboratories (XCNQ:GLAB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Gemina Laboratories's Gross Margin % for the three months ended in Apr. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Gemina Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

GLABF:USA

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories Headlines

No Headlines